Ga verder naar de inhoud

Vixen Bio Automated, medium-throughput analysis solution

Challenge

The sophisticated sensor technology for biomolecular interaction analysis originates from research performed at KU Leuven, and can disrupt the development and production of biological antibody-based medicines. But they needed to turn the technology into a scalable device.

Solution

The project team translated the laboratory analysis setup into a market-ready product. They developed a technically refined instrument that integrates the revolutionary optical fiber biosensing technology into an automated unit.

The collaboration with Comate is built on our belief that its design and engineering specialists are perfectly fit for the challenge. From a realistic viewpoint, it did not make sense to develop the performant analysis machine by ourselves.

Filip Delport
CEO Vixen Bio